Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 19;10(11):1418.
doi: 10.3390/antibiotics10111418.

Susceptibility to Nisin, Bactofencin, Pediocin and Reuterin of Multidrug Resistant Staphylococcus aureus, Streptococcus dysgalactiae and Streptococcus uberis Causing Bovine Mastitis

Affiliations

Susceptibility to Nisin, Bactofencin, Pediocin and Reuterin of Multidrug Resistant Staphylococcus aureus, Streptococcus dysgalactiae and Streptococcus uberis Causing Bovine Mastitis

Samantha Bennett et al. Antibiotics (Basel). .

Abstract

Antibiotics are the most effective strategy to prevent and treat intramammary infections. However, their misuse has led to the dissemination of multidrug resistant bacteria (MDR) for both animals and humans. Efforts to develop new alternative strategies to control bacterial infections related to MDR are continuously on the rise. The objective of this study was to evaluate the antimicrobial activity of different bacteriocins and reuterin against MDR Staphylococcus and Streptococcus clinical isolates involved in bovine mastitis. A bacterial collection including S. aureus (n = 19), S. dysgalactiae (n = 17) and S. uberis (n = 19) was assembled for this study. Antibiotic resistance profiles were determined by the disk diffusion method. In addition, sensitivity to bacteriocins and reuterin was evaluated by determining minimum inhibitory concentrations (MIC). A total of 21 strains (37.5%) were MDR. MICs ranged from ≤1.0 μg/mL to ≥100 μg/mL for nisin and 2.0 to ≥250 μg/mL for bactofencin. Reuterin was active against all tested bacteria, and MICs vary between 70 and 560 μg/mL. Interestingly, 20 MDR strains were inhibited by bactofencin at a concentration of ≤250 μg/mL, while 14 were inhibited by nisin at an MIC of ≤100 μg/mL. Pediocin did not show an inhibitory effect.

Keywords: alternative to antibiotics; antibiotic resistance; bacteriocin; dairy cows; intramammary infection; reuterin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
HPLC chromatogram profiles of purified antimicrobials. (A), bactofencin; (B), pediocin PA-1; (C), reuterin and (D), nisin, where mAU is the intensity of absorbance.
Figure 2
Figure 2
The antimicrobial activity of nisin (250 μg/mL), bactofencin A (250 μg/mL), pediocin PA-1 (250 μg/mL) and reuterin (3.7 mg/mL) against MDR (A) Staphylococcus aureus 40709611 [PEN-CEF-FOX-CTX-ERY-CHL-KAN-GEN-PEN/NOV] and (B) Staphylococcus aureus 40410425 [VAN-FOX-CTX-ERY-CHL-TET-KAN-GEN].

References

    1. Centers for Disease Control and Prevention Antibiotic/Antimicrobial Resistance. [(accessed on 3 November 2021)];2020 July 20; Available online: https://www.cdc.gov/drugresistance/index.html.
    1. Watkins R.R., Bonomo R.A. Overview: Global and local impact of antibiotic resistance. Infect. Dis. Clin. N. Am. 2016;30:313–322. doi: 10.1016/j.idc.2016.02.001. - DOI - PubMed
    1. Rice L.B. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No eskape. J. Infect. Dis. 2008;197:1079–1081. doi: 10.1086/533452. - DOI - PubMed
    1. Sears D., Schwartz B.S. Candida auris: An emerging multidrug-resistant pathogen. Int. J. Infect. Dis. 2017;63:95–98. doi: 10.1016/j.ijid.2017.08.017. - DOI - PubMed
    1. Ventola C.L. The antibiotic resistance crisis: Part 1: Causes and threats. Pharm. Ther. 2015;40:277–283. - PMC - PubMed

LinkOut - more resources